Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ebastine

A second-generation H1 antihistamine, patented in 1983 and in use since 1990 mainly for allergic rhinitis and chronic urticaria; little of it enters the brain, so it rarely causes drowsiness. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It works mostly through a stand-in: on its first pass through the liver it is converted into carebastine, the molecule that actually carries out the antihistamine action.

EbastineGo to the active ingredient →
EbastineActive ingredientEbastineCat. No. P-E001-001CAS 90729-43-4
Ebastine-d5Isotopically labelledEbastine-d5Cat. No. P-E001-010CAS 1216953-13-7

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Reference substanceEbastine CRSEDQM code Y0002031Family Ebastine

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.